Download PDF

Other users also viewed these articles

The ¿autoimmune/inflammatory syndrome induced by adjuvants¿ (ASIA) after COVID-19 infection: A case report Patricia Aguilera-Fernandez; María del Carmen Navarro-Saez; Carlos Feijoo-Massó; Enrique Esteve-Valverde; Sonia Calzado Isbert; Tamara Parra Parente;
Reumatol Clin. 2023;19:593-5
Cytokine storm in Chikungunya: Can we call it multisystem inflammatory syndrome associated with Chikungunya? Zoilo Morel; Tamara Martínez; Fernando Galeano; Judith Coronel; Lorena Quintero; Rolando Jimenez; Jorge Ayala; Sara Amarilla; Dolores Lovera; Celia Martínez de Cuellar;
Reumatol Clin. 2024;20:223-5
The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from Vietnam Hai-Binh Bui; Hong-Thinh Lai; Thanh-Lam Nguyen; Thuy-Duong Vu; Nhat-Le Bui; Van-Hung Nguyen; Thi-To-Chau Tran; Thi-Phuong-Thuy Nguyen; Thi-Ngoc-Lan Nguyen; Jaffar A. Al-Tawfiq; Dinh-Toi Chu;
Reumatol Clin. 2024;20:128-35